{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:25:38Z","timestamp":1794590738304,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CSL fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05510-7","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T03:30:20Z","timestamp":1756783820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strengthening country ownership of national antimalarial policymaking: insights from Laos, Pakistan and the Solomon Islands"],"prefix":"10.1186","volume":"24","author":[{"given":"Varunika S. H.","family":"Ruwanpura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilayphone","family":"Phongchantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ric N.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen Peeters","family":"Grietens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"5510_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000113","volume":"2","author":"AM Noor","year":"2022","unstructured":"Noor AM. Country ownership in global health. PLoS Glob Public Health. 2022;2: e0000113.","journal-title":"PLoS Glob Public Health"},{"key":"5510_CR2","unstructured":"Stephanie Watson-Grant D, Khou Xiong, MPH, James C. Thomas, PhD MEASURE Evaluation. Country ownership in international development toward a working definition. USA: University of North Carolina, 2016."},{"key":"5510_CR3","unstructured":"Global Fund The Global Fund Results Report 2024. Geneva: The Global Fund, 2024 September 2024."},{"key":"5510_CR4","unstructured":"WHO. Guidelines for malaria, 30 November 2024 Geneva: World Health Organization; 2024 Rev 8.2"},{"key":"5510_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4269\/ajtmh.23-0041","volume":"108","author":"ML Wilson","year":"2023","unstructured":"Wilson ML. The importance of local context in national malaria elimination efforts. Am J Trop Med Hyg. 2023;108:637\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5510_CR6","unstructured":"RBM Partnership to End Malaria. Geneva: UNOPS; 2024 [cited 2024 27\/10\/24]. Available from: https:\/\/endmalaria.org\/."},{"key":"5510_CR7","unstructured":"Donini C. New tools in the pipeline. APMEN Vivax WG Meeting. online: Medicines for Malaria Venture; 2024."},{"key":"5510_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijid.2023.03.010","volume":"130","author":"SA Woon","year":"2023","unstructured":"Woon SA, Moore BR, Laman M, Tesine P, Lorry L, Kasian B, et al. Ultra-short course, high-dose primaquine to prevent Plasmodium vivax infection following uncomplicated pediatric malaria: a randomized, open-label, non-inferiority trial of early versus delayed treatment. Int J Infect Dis. 2023;130:189\u201395.","journal-title":"Int J Infect Dis"},{"key":"5510_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(19)31285-1","volume":"394","author":"WRJ Taylor","year":"2019","unstructured":"Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, et al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394:929\u201338.","journal-title":"Lancet"},{"key":"5510_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med"},{"key":"5510_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1473-3099(23)00265-7","volume":"23","author":"K Thriemer","year":"2023","unstructured":"Thriemer K, Commons RJ. Tafenoquine and artemisinin-based combination therapy for vivax malaria: end of the road or just the beginning? Lancet Infect Dis. 2023;23:1100\u20132.","journal-title":"Lancet Infect Dis"},{"key":"5510_CR12","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/pathogens12050650","volume":"12","author":"A Sadhewa","year":"2023","unstructured":"Sadhewa A, Cassidy-Seyoum S, Acharya S, Devine A, Price RN, Mwaura M, et al. A review of the current status of G6PD deficiency testing to guide radical cure treatment for vivax malaria. Pathogens. 2023;12:650.","journal-title":"Pathogens"},{"key":"5510_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","volume":"100","author":"S Pal","year":"2019","unstructured":"Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, et al. Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient. Am J Trop Med Hyg. 2019;100:213\u201321.","journal-title":"Am J Trop Med Hyg"},{"key":"5510_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002990","volume":"4","author":"VSH Ruwanpura","year":"2024","unstructured":"Ruwanpura VSH, Grietens KP, Price RN, Thriemer K. Evidence uptake is only part of the process: stakeholders\u2019 insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria. PLoS Glob Public Health. 2024;4: e0002990.","journal-title":"PLoS Glob Public Health"},{"key":"5510_CR15","volume-title":"Quality assurance policy for pharmaceutical products","author":"Global Fund","year":"2023","unstructured":"Global Fund. Quality assurance policy for pharmaceutical products. Geneva: The Global Fund; 2023."},{"key":"5510_CR16","unstructured":"Drugs.com. FDA Approves Krintafel USA: Drugs.com; 2018 [cited 2024 07\/07\/24]. Available from: https:\/\/www.drugs.com\/newdrugs\/fda-approves-krintafel-tafenoquine-radical-cure-plasmodium-vivax-malaria-4786.html."},{"key":"5510_CR17","unstructured":"Australia G. Kozenis (tafenoquine) approved by the Australian TGA for the radical cure of P. vivax malaria Australia: GSK Australia; 2018 [cited 2024 07\/07\/24]. Available from: https:\/\/au.gsk.com\/en-au\/media\/press-releases\/kozenis-tafenoquine-approved-by-the-australian-tga-for-the-radical-cure-of-p-vivax-malaria\/."},{"key":"5510_CR18","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2024 [cited 2024 19\/12\/24]. Available from: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria."},{"key":"5510_CR19","unstructured":"WHO. In Vitro Diagnostics. Geneva: World Health Organization; 2024 [cited 2024 16\/11\/24]. Available from: https:\/\/extranet.who.int\/prequal\/vitro-diagnostics\/pipeline\/0581-117-00."},{"key":"5510_CR20","unstructured":"PATH. Expert Review Panel for Diagnostics approval expands access to a G6PD deficiency test that supports P. vivax malaria treatment and elimination initiatives. Seattle, Washington: PATH; 2019 [cited 2024 16\/11\/24]. Available from: https:\/\/www.path.org\/our-impact\/articles\/expert-review-panel-diagnostics-approval-expands-access-g6pd-deficiency-test-supports-p-vivax-malaria-treatment-and-elimination-initiatives\/."},{"key":"5510_CR21","unstructured":"WHO. List of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2024 [cited 2025 08\/02\/24]. Available from: https:\/\/extranet.who.int\/prequal\/vitro-diagnostics\/prequalified\/in-vitro-diagnostics."},{"key":"5510_CR22","unstructured":"WHO to begin development of parallel recommendation and regulatory pathways; shortening the time taken for people to access health products. Geneva: World Health Organization; 2024 [cited 2024 15\/05\/24]. Available from: https:\/\/extranet.who.int\/prequal\/news\/who-begin-development-parallel-recommendation-and-regulatory-pathways-shortening-time-taken."},{"key":"5510_CR23","unstructured":"MMV. Tafenoquine. Geneva: Medicines for Malaria Venture; 2024 [cited 2024 16\/11\/24]. Available from: https:\/\/www.mmv.org\/mmv-pipeline-antimalarial-drugs\/tafenoquine."},{"key":"5510_CR24","unstructured":"(NCEZID) NCfEaZID, (DGMH) DoGMH. Travellers\u2019 Health USA: Centres for Disease Control and Prevention; 2023 [cited 2024 16\/11\/24]. Available from: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/preparing\/yellow-fever-vaccine-malaria-prevention-by-country\/costa-rica."},{"key":"5510_CR25","unstructured":"Hub PvI. Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria. Geneva: Medicines for Malaria Venture; 2023 [cited 2023 June 9]. Available from: https:\/\/www.vivaxmalaria.org\/news\/brazil-becomes-the-first-malaria-endemic-country-to-adopt-single-dose-tafenoquine-and-standard."},{"key":"5510_CR26","unstructured":"Hub PvI. Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of P. vivax malaria. Geneva: Medicines for Malaria Venture; 2023 [cited 2023 August 7]. Available from: https:\/\/www.vivaxmalaria.org\/the-p-vivax-information-hub."},{"key":"5510_CR27","unstructured":"MMV. Brazil and Thailand become first malaria-endemic countries to launch new single-dose radical cure medicine to prevent the relapse of Plasmodium vivax malaria. Geneva: Medicines for Malaria Venture; 2024 [cited 2024 25\/07\/24]. Available from: https:\/\/www.mmv.org\/newsroom\/news-resources-search\/brazil-and-thailand-become-first-malaria-endemic-countries-launch."},{"key":"5510_CR28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/cid\/ciy735","volume":"68","author":"CS Chu","year":"2019","unstructured":"Chu CS, Phyo AP, Turner C, Win HH, Poe NP, Yotyingaphiram W, et al. Chloroquine versus dihydroartemisinin-piperaquine with standard high-dose primaquine given either for 7 days or 14 days in Plasmodium vivax malaria. Clin Infect Dis. 2019;68:1311\u20139.","journal-title":"Clin Infect Dis"},{"key":"5510_CR29","unstructured":"WHO. Guidelines for malaria, 25 November 2022. Geneva: World Health Organization, 2022 Rev.3."},{"key":"5510_CR30","unstructured":"Worldometer: Worldometer.info; 2023 [cited 2023 13\/09\/23]. Available from: https:\/\/www.worldometers.info\/world-population\/laos-population\/#:~:text=Population%20of%20Laos%20%282023%20and%20historical%29%20%20,%20%20106%20%2012%20more%20rows%20."},{"key":"5510_CR31","unstructured":"Group TWB. https:\/\/www.worldbank.org\/en\/country\/lao\/publication\/lao-economic-monitor-november-2023-fiscal-policy-for-stability-key-findings Washington DC: The World Bank Group; 2023 [cited 2023 15\/06\/24]. Available from: https:\/\/www.worldbank.org\/en\/country\/lao\/publication\/lao-economic-monitor-november-2023-fiscal-policy-for-stability-key-findings."},{"key":"5510_CR32","unstructured":"Islands NPotS. The National Parliament of Solomon Islands has passed the 2023 Budget Honiara: National Parliament of the Solomon Islands; 2022 [cited 2024 16\/06\/24]. Available from: https:\/\/www.parliament.gov.sb\/index.php\/article\/parliament-approves-2023-appropriation-bill-2022."},{"key":"5510_CR33","unstructured":"Saeed J. Analyzing Health Budget 2023 in Context of Wellbeing of People Islamabad: Sustainable Development Policy Institute; 2023 [cited 2024 15\/06\/24]. Available from: https:\/\/sdpi.org\/analyzing-health-budget-2023-in-context-of-wellbeing-of-people\/news_detail."},{"key":"5510_CR34","unstructured":"Regional WHO, Pacific OftW. Overview of Lao health system development 2009\u20132017. Manila, Phillipines: World Health Organization, 2018."},{"key":"5510_CR35","unstructured":"WHO. Solomon Islands health system review. World Health Organization Regional Office for the Western Pacific. 2015."},{"key":"5510_CR36","unstructured":"Alliance APLM. Presenting APLMA Leaders\u2019 Dashboard 2021:Tracking Progress Towards Malaria Elimination Singapore: Asia Pacific Leaders Malaria Alliance; 2022 [cited 2022 31\/03\/22]. Available from: https:\/\/www.youtube.com\/watch?v=ns1VRZ7MINM."},{"key":"5510_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/00358533.2020.1757285","volume":"109","author":"I Niaz","year":"2020","unstructured":"Niaz I. Pakistan, Covid-19, and the end of the neo-liberal disorder. The Round Table. 2020;109:324\u20135.","journal-title":"The Round Table"},{"key":"5510_CR38","unstructured":"The Government of Pakistan ADB, European Union, United Nations Development Programme, World Bank. Pakistan floods 2022: Post-disaster needs assessment. Islamabad: 2022."},{"key":"5510_CR39","unstructured":"Malaria Atlas Project Australia: Curtin University; 2023 [cited 2023 07\/06\/23]. Available from: https:\/\/malariaatlas.org\/."},{"key":"5510_CR40","unstructured":"Alliance ET. The challenge of tackling malaria in the Solomon Islands Mauritius: ERADA Technology Alliance Ltd.; 2020 [cited 2023 15\/09\/23]. Available from: https:\/\/www.eradatechnology.com\/the-challenge-of-tackling-malaria-in-the-solomon-islands\/."},{"key":"5510_CR41","unstructured":"WHO. World Malaria Report 2022. Geneva: World Health Organization; 2022 [cited 2022 10\/12\/22]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240064898."},{"key":"5510_CR42","unstructured":"APMEN. Accelerating implementation of radical cure for vivax malaria in Pakistan Singapore: Asia Pacific Malaria Elimination Network; 2022 [cited 2023 14\/09\/23]. Available from: https:\/\/apmen.org\/blog\/accelerating-implementation-radical-cure-vivax-malaria-pakistan."},{"key":"5510_CR43","volume-title":"K Case Study Research: Design and Methods","author":"R Yin","year":"2009","unstructured":"Yin R. K Case Study Research: Design and Methods. 4th ed. California: SAGE Publications; 2009.","edition":"4"},{"key":"5510_CR44","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.2105\/AJPH.2009.183939","volume":"100","author":"RL Craig","year":"2010","unstructured":"Craig RL, Felix HC, Walker JF, Phillips MM. Public health professionals as policy entrepreneurs: Arkansas\u2019s childhood obesity policy experience. Am J Public Health. 2010;100:2047\u201352.","journal-title":"Am J Public Health"},{"key":"5510_CR45","first-page":"93","volume":"18","author":"SL Mosier","year":"2013","unstructured":"Mosier SL. Cookies, candy, and coke: examining state sugar-sweetened-beverage tax policy from a multiple streams approach. Int Rev Public Adm. 2013;18:93\u2013120.","journal-title":"Int Rev Public Adm"},{"key":"5510_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/0958159031000097625","volume":"13","author":"HR Yeatman","year":"2003","unstructured":"Yeatman HR. Food and nutrition policy at the local level: key factors that influence the policy development process. Crit Public Health. 2003;13:125\u201338.","journal-title":"Crit Public Health"},{"key":"5510_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/13563475.2013.750939","volume":"18","author":"M Caraher","year":"2013","unstructured":"Caraher M, Carey R, McConell K, Lawrence M. Food policy development in the Australian State of Victoria: a case study of the food alliance. Int Plan Stud. 2013;18:78\u201395.","journal-title":"Int Plan Stud"},{"key":"5510_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/heapro\/day052","volume":"34","author":"J Browne","year":"2019","unstructured":"Browne J, Coffey B, Cook K, Meiklejohn S, Palermo C. A guide to policy analysis as a research method. Health Promot Int. 2019;34:1032\u201344.","journal-title":"Health Promot Int"},{"key":"5510_CR49","first-page":"228","volume":"18","author":"D B\u00e9land","year":"2016","unstructured":"B\u00e9land D. Kingdon reconsidered: ideas, interests and institutions in comparative policy analysis. J Comp Policy Anal. 2016;18:228\u201342.","journal-title":"J Comp Policy Anal"},{"key":"5510_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12936-021-03959-w","volume":"20","author":"V Ruwanpura","year":"2021","unstructured":"Ruwanpura V, Neukom J, Grietens KP, Price RN, Thriemer K, Lynch CA. Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries. Malar J. 2021;20:428.","journal-title":"Malar J"},{"key":"5510_CR51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/app5.314","volume":"8","author":"VSH Ruwanpura","year":"2021","unstructured":"Ruwanpura VSH, Nowak S, Gerth-Guyette E, Theodora M, Dysoley L, Haile M, et al. Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: insights from the 2019 annual APMEN vivax working group meeting. Asia Pac Policy Stud. 2021;8:208\u201342.","journal-title":"Asia Pac Policy Stud"},{"key":"5510_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/heapol\/9.4.353","volume":"9","author":"G Walt","year":"1994","unstructured":"Walt G, Gilson L. Reforming the health sector in developing countries: the central role of policy analysis. Health Policy Plan. 1994;9:353\u201370.","journal-title":"Health Policy Plan"},{"key":"5510_CR53","volume-title":"Systematic review: what are the effects of interventions to improve the uptake of evidence from health research into policy in low and middle-income countries?","author":"C Clar","year":"2011","unstructured":"Clar C, Graham W, Davidson L, Campbell S. Systematic review: what are the effects of interventions to improve the uptake of evidence from health research into policy in low and middle-income countries? Aberdeen: University of Aberdeen; 2011."},{"key":"5510_CR54","unstructured":"Gauvin F. Understanding Policy Developments and Choices Through the \u201c3-i\u201d Framework: Interests, Ideas and Institutions Montreal, Quebec: National Collaborating Centre for Healthy Public Policy; 2014 [cited 2020 28\/01\/2020]. Briefing paper on health policy]. Available from: http:\/\/www.ncchpp.ca\/docs\/2014_procpp_3iframework_en.pdf."},{"key":"5510_CR55","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/S0140-6736(07)61579-7","volume":"370","author":"J Shiffman","year":"2007","unstructured":"Shiffman J, Smith S. Generation of political priority for global health initiatives: a framework and case study of maternal mortality. Lancet. 2007;370:1370\u20139.","journal-title":"Lancet"},{"key":"5510_CR56","unstructured":"OECD. Country ownership over national development processes. Paris: Organisation for Economic Co-operation and Development 2024 [cited 2025 04\/05\/25]. Available from: https:\/\/www.oecd.org\/en\/publications\/development-co-operation-tips-tools-insights-practices_be69e0cf-en\/country-ownership-over-national-development-processes_1a0df804-en.html."},{"key":"5510_CR57","doi-asserted-by":"crossref","unstructured":"Boughton JM, Mourmouras A, Gilbert CL, Vines D. Whose programme is it? Policy ownership and conditional lending. Series Number 5. United Kingdom: Cambridge University Press; 2004. p. 225\u201353.","DOI":"10.1017\/CBO9780511493362.010"},{"key":"5510_CR58","volume-title":"Agendas, alternatives, and public policies","author":"JW Kingdon","year":"1995","unstructured":"Kingdon JW. Agendas, alternatives, and public policies. 2nd ed. New York: Harper Collins College; 1995.","edition":"2"},{"key":"5510_CR59","unstructured":"Charmaz K. Constructing grounded theory. 2nd edn: Sage; 2014."},{"key":"5510_CR60","unstructured":"Zoom [Computer Software]. 55 Almaden Blvd., 6th Floor, San Jose, CA 95113: Zoom Video Communications, Inc.; 2022."},{"key":"5510_CR61","unstructured":"Otter.ai 800 W. El Camino Real, Suite 170, Mountain View, CA 94040.: Otter.ai; 2020 [cited 2022 12\/02\/22]. Available from: https:\/\/otter.ai\/."},{"key":"5510_CR62","unstructured":"NVivo12. QSR International Pty Ltd.; 2018 [cited 2020 10\/03\/20]. Available from: https:\/\/www.qsrinternational.com\/nvivo-qualitative-data-analysis-software\/home."},{"key":"5510_CR63","doi-asserted-by":"crossref","unstructured":"Booth A, Hannes K, Harden A, Noyes J, Harris J, Tong A. COREQ (Consolidated Criteria for Reporting Qualitative Studies). Guidelines for Reporting Health Research: A User\u2019s Manual. 2014. p. 214\u201326.","DOI":"10.1002\/9781118715598.ch21"},{"key":"5510_CR64","unstructured":"Shretta R, Silal S, Celhay O, Mercado C, Kyaw SS, Avancena ALV, et al. An investment case for eliminating malaria in the Greater Mekong Subregion. UCSF: The Global Health Group, San Francisco, 2017."},{"key":"5510_CR65","unstructured":"WHO. How WHO is funded. Geneva: World Health Organization; 2023 [cited 2023 13\/07\/23]. Available from: https:\/\/www.who.int\/about\/funding\/."},{"key":"5510_CR66","unstructured":"WHO. Seventy-sixth World Health Assembly. Geneva, World Health Organization; 2023 [cited 2024 27\/07\/24]. Available from: https:\/\/www.who.int\/about\/governance\/world-health-assembly\/seventy-sixth-world-health-assembly."},{"key":"5510_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/heapol\/czx145","volume":"33","author":"MS Khan","year":"2018","unstructured":"Khan MS, Meghani A, Liverani M, Roychowdhury I, Parkhurst J. How do external donors influence national health policy processes? Experiences of domestic policy actors in Cambodia and Pakistan. Health Policy Plan. 2018;33:215\u201323.","journal-title":"Health Policy Plan"},{"issue":"4","key":"5510_CR68","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/heapro\/dap033","volume":"24","author":"K Guldbrandsson","year":"2009","unstructured":"Guldbrandsson K, Fossum B. An exploration of the theoretical concepts policy windows and policy entrepreneurs at the Swedish public health arena. Health Promot Int. 2009;24(4):434\u201344.","journal-title":"Health Promot Int"},{"key":"5510_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003914","volume":"4","author":"N Salisbury","year":"2024","unstructured":"Salisbury N, Nawaz S, Abenaitwe J, Batzel A, Grapa E, Casas F, et al. Ambitions and realities: are Global Fund investments designed to achieve resilient and sustainable systems for health? Findings from the Global Fund prospective country evaluation. PLoS Glob Public Health. 2024;4: e0003914.","journal-title":"PLoS Glob Public Health"},{"key":"5510_CR70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.15171\/ijhpm.2016.118","volume":"6","author":"K Chalkidou","year":"2017","unstructured":"Chalkidou K, Li R, Culyer AJ, Glassman A, Hofman KJ, Teerawattananon Y. Health technology assessment: global advocacy and local realities comment on \u201cPriority Setting for Universal Health Coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness.\u201d Int J Health Policy Manag. 2017;6:233\u20136.","journal-title":"Int J Health Policy Manag"},{"key":"5510_CR71","unstructured":"Glassman A, Chalkidou K, chairs. Priority-setting in Health Building institutions for smarter public spending. Washington DC: Center for Global Development, 2012."},{"key":"5510_CR72","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10966.1","volume":"6","author":"R Li","year":"2017","unstructured":"Li R, Ruiz F, Culyer AJ, Chalkidou K, Hofman KJ. Evidence-informed capacity building for setting health priorities in low- and middle-income countries: a framework and recommendations for further research. F1000Res. 2017;6: 231.","journal-title":"F1000Res"},{"key":"5510_CR73","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/01436590701192231","volume":"28","author":"J Best","year":"2007","unstructured":"Best J. Legitimacy dilemmas: the IMF\u2019s pursuit of country ownership. Third World Q. 2007;28:469\u201388.","journal-title":"Third World Q"},{"key":"5510_CR74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1473-3099(07)70026-9","volume":"7","author":"J Crawley","year":"2007","unstructured":"Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, et al. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy. Lancet Infect Dis. 2007;7:145\u201355.","journal-title":"Lancet Infect Dis"},{"key":"5510_CR75","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12936-023-04763-4","volume":"22","author":"VAT Cao","year":"2023","unstructured":"Cao VAT, Nguyen TQ, Le Quyen D, Boon WPC, Moors EHM, Dondorp AM, et al. Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam. Malar J. 2023;22:326.","journal-title":"Malar J"},{"key":"5510_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE. 2016;11: e0150205.","journal-title":"PLoS ONE"},{"key":"5510_CR77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2288-10-67","volume":"10","author":"M Arain","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.","journal-title":"BMC Med Res Methodol"},{"key":"5510_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108787","volume":"9","author":"S McGregor","year":"2014","unstructured":"McGregor S, Henderson KJ, Kaldor JM. How are health research priorities set in low and middle income countries? A systematic review of published reports. PLoS ONE. 2014;9: e108787.","journal-title":"PLoS ONE"},{"key":"5510_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003944","volume":"19","author":"EF Peacocke","year":"2022","unstructured":"Peacocke EF, Myhre SL, Foss HS, Gopinathan U. National adaptation and implementation of WHO model list of essential medicines: a qualitative evidence synthesis. PLoS Med. 2022;19: e1003944.","journal-title":"PLoS Med"},{"key":"5510_CR80","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/S0140-6736(18)32205-0","volume":"392","author":"S Theobald","year":"2018","unstructured":"Theobald S, Brandes N, Gyapong M, El-Saharty S, Proctor E, Diaz T, et al. Implementation research: new imperatives and opportunities in global health. Lancet. 2018;392:2214\u201328.","journal-title":"Lancet"},{"key":"5510_CR81","doi-asserted-by":"publisher","first-page":"117863292199965","DOI":"10.1177\/1178632921999652","volume":"14","author":"T Ojo","year":"2021","unstructured":"Ojo T, Kabasele L, Boyd B, Enechukwu S, Ryan N, Gyamfi J, et al. The role of implementation science in advancing resource generation for health interventions in low- and middle-income countries. Health Serv Insights. 2021;14:1178632921999652.","journal-title":"Health Serv Insights"},{"key":"5510_CR82","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/heapol\/czn019","volume":"23","author":"L Gilson","year":"2008","unstructured":"Gilson L, Raphaely N. The terrain of health policy analysis in low and middle income countries: a review of published literature 1994\u20132007. Health Policy Plan. 2008;23:294\u2013307.","journal-title":"Health Policy Plan"},{"key":"5510_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280950","volume":"18","author":"M Shrestha","year":"2023","unstructured":"Shrestha M, Neukom J, Acharya S, Habib MN, Wini L, Duong TT, et al. Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts. PLoS ONE. 2023;18: e0280950.","journal-title":"PLoS ONE"},{"key":"5510_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002970","volume":"4","author":"S Acharya","year":"2024","unstructured":"Acharya S, Shrestha M, Thang ND, Wini L, Habib MN, Neukom J, et al. Optimizing test and treat options for vivax malaria: an options assessment toolkit (OAT) for Asia Pacific national malaria control programs. PLoS Glob Public Health. 2024;4: e0002970.","journal-title":"PLoS Glob Public Health"},{"key":"5510_CR85","unstructured":"TDR tSPfRaTiTD. SORT IT operational research and training Geneva, Switzerland: TDR, the Special Programme for Research and Training in Tropical Diseases; 2022 [cited 2024 24\/11\/24]. Available from: https:\/\/tdr.who.int\/activities\/tackling-antimicrobial-resistance\/sort-it-operational-research-and-training#:~:text=SORT%20IT%20is%20a%20global%20partnership%20coordinated%20by,and%20make%20evidence-informed%20decisions%20for%20improving%20programme%20performance."},{"key":"5510_CR86","volume-title":"Health intervention and Technology Assessment Program (HITAP)\u2014Health Technology Assessment Process Guidelines","author":"R Velasco","year":"2012","unstructured":"Velasco R, Chaikledkaew U, Youngkong S, Tantivess S, Teerawattananon Y. Health intervention and Technology Assessment Program (HITAP)\u2014Health Technology Assessment Process Guidelines. Thailand: Ministry of Public Health; 2012."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05510-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:25:46Z","timestamp":1756898746000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05510-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5510"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05510-7","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Office of Research and Innovation, Charles Darwin University, Australia (H19081) and received a waiver of full ethical review by the Human Research Ethics Committee of the Australian Northern Territory. The study was also approved by the Solomon Islands Ministry of Health\u2019s research and ethics review board (HRE005\/23) for the in-country case study. All participants provided consent before being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}